- Q2 2024 Cue Biopharma Inc Earnings Call Transcript6 days ago€0.585 (+9.35%)Earnings
- Q4 2023 Cue Biopharma Inc Earnings Call TranscriptApr 08, 2024€1.7 (+4.94%)Earnings
- Q3 2023 Cue Biopharma Inc Earnings Call and Business Update TranscriptNov 09, 2023€2.24 (-4.36%)Earnings
- Q2 2023 Cue Biopharma Inc Earnings Call TranscriptAug 09, 2023€3.2 (+3.16%)Earnings
- Cue Biopharma Inc To Host Business Update Call TranscriptJun 14, 2023
- Cue Biopharma Inc at Jefferies Healthcare Conference TranscriptJun 09, 2023
- Cue Biopharma Inc at JMP Securities Life Sciences Conference TranscriptMay 15, 2023
- Q4 2022 Cue Biopharma Inc Earnings Call TranscriptMar 21, 2023€2.86 (+2.14%)Earnings
- Q3 2022 Cue Biopharma Inc Earnings Call TranscriptNov 14, 2022€3Earnings
- Q2 2022 Cue Biopharma Inc Earnings And Business Update Call TranscriptAug 23, 2022
- Cue Biopharma Inc at JMP Securities Life Sciences Conference TranscriptJun 16, 2022
- Cue Biopharma Inc To Host Business Update And Ongoing CUE-101 Clinical Trials Call TranscriptJan 26, 2022
- Q2 2021 Cue Biopharma Inc Earnings Call TranscriptAug 17, 2021€8.45 (-8.65%)Earnings
- Q1 2021 Cue Biopharma Inc Earnings Call TranscriptMay 17, 2021€11.1 (+5.71%)Earnings
- Q4 2020 Cue Biopharma Inc Earnings Call TranscriptMar 16, 2021€12.5 (+5.93%)Earnings
- Cue Biopharma Inc at Cowen Healthcare Conference (Virtual) TranscriptMar 04, 2021
- Cue Biopharma, Inc. - Special Call TranscriptNov 17, 2020
- Cue Biopharma Inc at Morgan Stanley Global Healthcare Conference (Virtual) TranscriptSep 17, 2020
- Q2 2020 Cue Biopharma Inc Earnings Call TranscriptAug 31, 2020€14.7 (-1.34%)Earnings
- Q1 2020 Cue Biopharma Inc Earnings Call TranscriptMay 19, 2020€24Earnings
- Q4 2019 Cue Biopharma Inc Earnings Call TranscriptMar 17, 2020€11.6Earnings
- Cue Biopharma, Inc. - Special Call TranscriptNov 12, 2019
- Cue Biopharma Inc Investor Business Update TranscriptMay 21, 2019
- Cue Biopharma, Inc. - Special Call TranscriptMar 14, 2019
Cue Biopharma Inc at Morgan Stanley Global Healthcare Conference (Virtual) Transcript
Good afternoon, everybody. Thank you for coming today for the Morgan Stanley Healthcare Conference. Today, this afternoon, I have with me Dan Passeri, the CEO of Cue. And why don't I pass it off to Dan to introduce the rest of the management team? The format here will be a 10-minute overview of the company followed by a Q&A led by me. (Operator Instructions) Dan?
Okay. Thanks, Albert. Good afternoon, everyone. I'm joined here by -- with my colleague, Anish Suri, who's President and Chief Scientific Officer of Cue Biopharma.
Just to remind everyone, Cue is a NASDAQ-listed company. Symbol is CUE. I also want to thank Morgan Stanley for giving us an opportunity to present.
I'm going to be advancing slides here at our facility, and I'll tell you which slides we're on. You can advance them off of your computers directly.
We're now moving to Slide 2.
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)